The Centre on Thursday said the shortage of Amphotericin B, a drug used to treat black fungus or mucormycosis patients, will be resolved soon as its production has been ramped up by the existing six pharmaceutical companies, and five more firms have received new drug approval for producing it in India.
Tweeting, Union Minister Mansukh Mandaviya said that Indian companies have also placed orders for importing six lakh vials of Amphotericin B, and the govt is leaving no stone unturned to resolve the crisis.
Earlier in the day, the Delhi High Court had asked the Centre to inform about steps taken to import medicine used for treating black fungus which is primarily affecting Covid-19 recovered people as the drug is in shortage in the country.